| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |